Literature DB >> 3545104

Carpal tunnel syndrome caused by amyloid containing beta 2 microglobulin: a new amyloid and a complication of long term haemodialysis.

J McClure, C J Bartley, P Ackrill.   

Abstract

Three patients receiving long term haemodialysis treatment for chronic renal failure due to non-amyloid nephropathy developed the carpal tunnel syndrome requiring decompression surgery. The excised material contained amyloid, which by immunocytochemical techniques was shown to contain beta 2 microglobulin. This is, therefore, a new chemical form of amyloid whose deposition is likely to be the cause of osteoarticular and connective tissue disorders, which are being recognised with increasing frequency in patients receiving long term haemodialysis. Raised beta 2 microglobulin levels are known to occur in chronic renal failure, and the molecule is unable to cross conventional dialysis membranes. The importance of beta 2 microglobulin amyloidosis lies in the threat which it poses to the success of long term haemodialysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3545104      PMCID: PMC1002041          DOI: 10.1136/ard.45.12.1007

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Serum 2 -microglobulin in renal disease.

Authors:  L Wibell; P E Evrin; I Berggård
Journal:  Nephron       Date:  1973       Impact factor: 2.847

2.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

3.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.

Authors:  F Gejyo; T Yamada; S Odani; Y Nakagawa; M Arakawa; T Kunitomo; H Kataoka; M Suzuki; Y Hirasawa; T Shirahama
Journal:  Biochem Biophys Res Commun       Date:  1985-06-28       Impact factor: 3.575

4.  Amyloid proteins, precursors, mediator, and enhancer.

Authors:  A S Cohen; T Shirahama; J D Sipe; M Skinner
Journal:  Lab Invest       Date:  1983-01       Impact factor: 5.662

5.  Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabeled immunoperoxidase method.

Authors:  S Fujihara; J E Balow; J C Costa; G G Glenner
Journal:  Lab Invest       Date:  1980-10       Impact factor: 5.662

6.  Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: a new complication.

Authors:  J Muñoz-Gómez; E Bergadá-Barado; R Gómez-Pérez; E Llopart-Buisán; E Subías-Sobrevía; J Rotés-Querol; M Solé-Arqués
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

7.  Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion.

Authors:  T Shirahama; M Skinner; P Westermark; A Rubinow; A S Cohen; A Brun; T L Kemper
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

8.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

9.  Serum beta2-microglobulin in hemodialyzed patients.

Authors:  C Vincent; J P Revillard; M Galland; J Traeger
Journal:  Nephron       Date:  1978       Impact factor: 2.847

10.  Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.

Authors:  K Sletten; P Westermark; J B Natvig
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  8 in total

1.  Systemic amyloidosis of beta 2 microglobulin type.

Authors:  K Mazanec; J McClure; C J Bartley; M J Newbould; P Ackrill
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

Review 2.  Does aluminium have a pathogenic role in dialysis associated arthropathy?

Authors:  P Netter; M Kessler; A Gaucher; B Bannwarth
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Immunohistological characterisation of amyloid deposits in renal biopsy specimens.

Authors:  R J Fitzmaurice; C Bartley; J McClure; P Ackrill
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 4.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on haemodialysis using cellulose membranes.

Authors:  J Muñoz-Gómez; R Gómez-Pérez; E Llopart-Buisán; M Solé-Arqués
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

6.  'Dialysis related arthropathy': a survey of 95 patients receiving chronic haemodialysis with special reference to beta 2 microglobulin related amyloidosis.

Authors:  N P Hurst; R van den Berg; A Disney; M Alcock; L Albertyn; M Green; V Pascoe
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

7.  Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.

Authors:  P Eldhagen; S Berg; L H Lund; P Sörensson; O B Suhr; P Westermark
Journal:  J Intern Med       Date:  2021-01-07       Impact factor: 8.989

8.  Carpal tunnel release surgery and venous hypertension in early hemodialysis patients without amyloid deposits.

Authors:  Ismail Kocyigit; Aydin Unal; Ahmet Guney; Ertugrul Mavili; Kemal Deniz; Merva Kocyigit; Murat Sipahioglu; Eray Eroglu; Bulent Tokgoz; Ali Ihsan Gunal; Oktay Oymak
Journal:  ScientificWorldJournal       Date:  2013-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.